Shift from Rh-positive to Rh-negative phenotype caused by a somatic mutation within the RHD gene in a patient with chronic myelocytic leukaemia

被引:16
作者
Chérif-Zahar, B
Bony, V
Steffensen, R
Gane, P
Raynal, V
Goosens, D
Laursen, JS
Varming, K
Jersild, G
Cartron, JP [1 ]
机构
[1] Inst Natl Transfus Sanguine, INSERM, U76, F-75739 Paris 15, France
[2] Aalborg Hosp, Reg Ctr Blood Transfus & Clin Immunol, Aalborg, Denmark
[3] Aalborg Hosp, Dept Haematol, Aalborg, Denmark
关键词
CML; RH locus; loss of D antigen; stem cell mutation; blood groups;
D O I
10.1046/j.1365-2141.1998.00895.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report a female patient whose Rh phenotype shifted from RhD-positive to RhD-negative over a 3-year period (1991-94), during which time she was treated with mastectomy (1992) and local irradiation for a low-grade recurrent breast cancer. She was diagnosed with chronic myeloid leukaemia in 1994, and has since then received chemotherapy, The patient was repeatedly typed as O, RhD-positive between 1965 and 1991 and was repeatedly found RhD-negative after 1994. Bcr-Abl transcripts typical of Phl chromosome were detected, Molecular analysis indicated that the patient was heterozygous at the RH locus, carrying one haplotype in which the RHD gene exhibited a single nucleotide deletion (G600) resulting in frameshift and premature stop codon, and a normal RHCE gene (allele Ce). The second haplotype contained only the RHCE gene (allele ce) and was normal, Further analysis carried put on total leucocytes, purified neutrophils, EBV-lymphoblastoid cell line and cultured erythroblasts indicated that the G600 deletion was restricted to the myeloid lineage, No modification of other blood group antigens could be detected, These findings suggest a somatic mutation which most probably occurred in a stem cell common to the myeloid lineage.
引用
收藏
页码:1263 / 1270
页数:8
相关论文
共 47 条
[1]   BIOCHEMICAL ASPECTS OF THE BLOOD-GROUP RH (RHESUS) ANTIGENS [J].
ANSTEE, DJ ;
TANNER, MJA .
BAILLIERES CLINICAL HAEMATOLOGY, 1993, 6 (02) :401-422
[2]   Evidence of genetic diversity underlying Rh D-, weak D (D-u), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of the RHD gene [J].
Avent, ND ;
Martin, PG ;
ArmstrongFisher, SS ;
Liu, W ;
Finning, KM ;
Maddocks, D ;
Urbaniak, SJ .
BLOOD, 1997, 89 (07) :2568-2577
[3]   PRENATAL DETERMINATION OF FETAL RHD TYPE BY DNA AMPLIFICATION [J].
BENNETT, PR ;
KIM, CL ;
COLIN, Y ;
WARWICK, RM ;
CHERIFZAHAR, B ;
FISK, NM ;
CARTRON, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (09) :607-610
[4]   RH MOSAICISM AND ABERRANT MNSS ANTIGEN EXPRESSION IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA [J].
BRACEY, AW ;
MCGINNISS, MH ;
LEVINE, RM ;
WHANGPENG, J .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1983, 79 (03) :397-401
[5]  
CALLENDER ST, 1971, BRIT MED J, V1, P31
[6]  
CARTRON JP, 1993, SEMIN HEMATOL, V30, P193
[7]   DEFINING THE RH BLOOD-GROUP ANTIGENS - BIOCHEMISTRY AND MOLECULAR-GENETICS [J].
CARTRON, JP .
BLOOD REVIEWS, 1994, 8 (04) :199-212
[8]   Molecular defects of the RHCE gene in Rh-deficient individuals of the amorph type [J].
Chérif-Zahar, B ;
Matassi, G ;
Raynal, V ;
Gane, P ;
Mempel, W ;
Perez, C ;
Cartron, JP .
BLOOD, 1998, 92 (02) :639-646
[9]   MOLECULAR-CLONING AND PROTEIN-STRUCTURE OF A HUMAN BLOOD-GROUP RH POLYPEPTIDE [J].
CHERIFZAHAR, B ;
BLOY, C ;
LEVANKIM, C ;
BLANCHARD, D ;
BAILLY, P ;
HERMAND, P ;
SALMON, C ;
CARTRON, JP ;
COLIN, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) :6243-6247
[10]   STRUCTURE AND EXPRESSION OF THE RH LOCUS IN THE RH-DEFICIENCY SYNDROME [J].
CHERIFZAHAR, B ;
RAYNAL, V ;
LEVANKIM, C ;
DAMBROSIO, AM ;
BAILLY, P ;
CARTRON, JP ;
COLIN, Y .
BLOOD, 1993, 82 (02) :656-662